Development and validation of a short questionnaire in community acquired pneumonia

R El Moussaoui, B C Opmeer, P M M Bossuyt, P Speelman, C A J M de Borgie, J M Prins, R El Moussaoui, B C Opmeer, P M M Bossuyt, P Speelman, C A J M de Borgie, J M Prins

Abstract

Background: A short but sensitive questionnaire evaluating changes in respiratory symptoms and well being during the treatment of community acquired pneumonia (CAP) is needed. We have developed a measurement and evaluated its psychometric properties in 67 patients admitted with CAP.

Methods: The patients were asked to indicate the presence and severity of dyspnoea, coughing, coughing up sputum, coughing up sputum with ease, the colour of the sputum, fatigue, fitness, and their state of health. The item fatigue showed substantial overlap with fitness and was therefore excluded. The response of the patients to the remaining eight items was used to calculate a CAP score.

Results: The percentage of missing data (0.2-1.7%), floor and ceiling effects (0.2/5.5%), internal consistency (Cronbach alpha = 0.87), and the intraclass correlation coefficient for test-retest reproducibility (0.83) met predefined criteria, indicating good acceptability and reliability. Face and clinical validity were satisfactory. Effect sizes under treatment were large, indicating high responsiveness.

Conclusion: The newly developed CAP score is a simple, reliable, valid, and highly responsive instrument. This makes it scientifically sound and clinically relevant for measuring outcome when evaluating treatment strategies in CAP.

References

    1. Med Care. 1989 Mar;27(3 Suppl):S178-89
    1. Med Care. 1979 Sep;17(9):902-21
    1. Med Care. 1994 Jan;32(1):40-66
    1. Clin Ther. 1996 Sep-Oct;18(5):979-92
    1. N Engl J Med. 1997 Jan 23;336(4):243-50
    1. JAMA. 1997 Jul 2;278(1):32-9
    1. Arch Intern Med. 1997 Jul 14;157(13):1453-9
    1. J Gen Intern Med. 1997 Jul;12(7):423-30
    1. Qual Life Res. 1997 Aug;6(6):561-71
    1. Clin Ther. 1998 Jul-Aug;20(4):820-37
    1. Respir Med. 1998 Sep;92(9):1137-42
    1. Arch Intern Med. 1999 May 10;159(9):970-80
    1. Clin Chest Med. 1999 Sep;20(3):623-51
    1. JAMA. 2000 Feb 9;283(6):749-55
    1. Clin Ther. 2000 Feb;22(2):250-64
    1. Clin Infect Dis. 2000 Aug;31(2):347-82
    1. J Gen Intern Med. 2000 Sep;15(9):638-46
    1. Clin Infect Dis. 2000 Dec;31(6):1362-7
    1. Pharmacotherapy. 2001 Jul;21(7 Pt 2):89S-94S
    1. Neurology. 2001 Aug 28;57(4):639-44
    1. Chest. 2002 Sep;122(3):920-9
    1. Eur Respir J. 2003 Jan;21(1):135-43
    1. Med Care. 1990 Jul;28(7):632-42

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj